Dr. Atkinson studies chronic and end-stage kidney disease in children, focusing on the mechanisms and treatment of anemia as well as the biologic and systematic factors that account for disparities in patient outcomes. Some of her latest work has concentrated on unraveling the interplay between vitamin D levels, anemia and race. She is also working to understand treatment outcomes in anemia.
Vitamin D as a Modifier of Serum Hepcidin in Children with Chronic Kidney Disease
Atkinson MA, Kim JY, Roy CN, Warady BA, White CT, Furth SL. "Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort." Pediatr Nephrol. 2014 Nov 8. [Epub ahead of print]
Dahlinghaus EK, Neu AM, Atkinson MA, Fadrowski JJ. "Hemoglobin level and risk of hospitalization and mortality in children on peritoneal dialysis." Pediatr Nephrol. 2014 Dec;29(12):2387-94. doi: 10.1007/s00467-014-2872-x. Epub 2014 Aug 10.
Lestz RM, Fivush BA, Atkinson MA. "Association of higher erythropoiesis stimulating agent dose and mortality in children on dialysis." Pediatr Nephrol. 2014 Oct;29(10):2021-8. doi: 10.1007/s00467-014-2820-9. Epub 2014 May 3.
Atkinson MA, Melamed ML, Kumar J, Roy CN, Miller ER 3rd, Furth SL, Fadrowski JJ. "Vitamin D, race, and risk for anemia in children." J Pediatr. 2014 Jan;164(1):153-158.e1. doi: 10.1016/j.jpeds.2013.08.060. Epub 2013 Oct 8.
Atkinson MA, Pierce CB, Fadrowski JJ, Benador NM, White CT, Turman MA, Pan CG, Abraham AG, Warady BA, Furth SL. "Association between common iron store markers and hemoglobin in children with chronic kidney disease." Pediatr Nephrol. 2012 Dec;27(12):2275-83. doi: 10.1007/s00467-012-2266-x. Epub 2012 Jul 27.